BlackRock’s EnteroMedics Inc. ETRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-17,668
Closed -$31K 5145
2017
Q3
$31K Hold
17,668
﹤0.01% 4535
2017
Q2
$88K Buy
17,668
+17,524
+12,169% +$87.2K ﹤0.01% 4428
2017
Q1
$1K Buy
+144
New +$1.06K ﹤0.01% 5005

Other funds holding ETRM

BlackRock's ETRM Position: Q4 2017 in Review

BlackRock sold out of EnteroMedics Inc. (ETRM) in Q4 2017, closing a stake of 17,668 shares — an estimated $31K sold.

BlackRock first reported a position in ETRM in Q1 2017 and held it in 3 quarters. The position peaked at $88K in Q2 2017. 1 fund tracked by Wall St. Rank holds ETRM as of Q4 2017.

  • BlackRock reported no remaining EnteroMedics Inc. position as of Q4 2017 after selling out during the quarter.
  • BlackRock sold 17,668 EnteroMedics Inc. shares in Q4 2017, an estimated $31K.
  • BlackRock first reported a position in EnteroMedics Inc. in Q1 2017 and held it in 3 quarters.
  • BlackRock's EnteroMedics Inc. position peaked at $88K in Q2 2017.
  • 1 fund tracked by Wall St. Rank held EnteroMedics Inc. as of Q4 2017.

Based on BlackRock's 13F filing for Q4 2017, filed 9 Feb 2018.